Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
PBYI —
PUMA BIOTECHNOLOGY INC
CUSIP: 74587V107 · Held by 3 superinvestors · Combined value: $13,771,829
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Jim Simons | 0.0% | $12,636,687 | 2,123,813 | REDUCE | -27,400 |
| 2 | Ken Griffin | 0.0% | $1,055,947 | 177,470 | ADD | +154,170 |
| 3 | Sarah Ketterer | 0.0% | $79,195 | 13,310 | REDUCE | -785 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Ken Griffin | ADD | +154,170 | +661.7% |
| Jim Simons | REDUCE | -27,400 | -1.3% |
| Sarah Ketterer | REDUCE | -785 | -5.6% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | ADD | +276,500 | +14.7% |
| Ken Griffin | REDUCE | -531,218 | -95.8% |
Who Owns PBYI? Superinvestor Holdings
PUMA BIOTECHNOLOGY INC is held by 3 tracked superinvestors, with a combined position value of $14 million . The largest positions are held by Jim Simons (0.0% of portfolio), Ken Griffin (0.0% of portfolio), Sarah Ketterer (0.0% of portfolio).
In the most recent quarter, 1 superinvestor added or initiated positions while 2 reduced or exited.